The structural modifications and immunochemical activities of several Streptococcus pneumoniae type 19A polysaccharide (PS) preparations have been studied by sugar compositional analysis and immunodiffusion. The 19A PS preparations Lab-A-1 and Lab-A-3 and one PS isolated from 19A strain OB contained fucose (Fuc) and galactose (Gal) in addition to rhamnose (Rha) and glucose (Glc). In contrast, 19A PSs Lab-A-2 and Lab-B contained only Rha and Glc. Despite their different sugar compositions, these 19A preparations appeared to be identical in serologic activity as measured by immunodiffusion with rabbit 19A and 19F antisera. The 19A PS Lab-A-1 was separated into three fractions by DEAE-Sepharose CL-6B column chromatography with a NaCl gradient. Fraction II was the major peak with a yield of 72.9%. Fraction Ia contained Fuc and Gal, while fraction II contained Fuc, Gal, Rha, and Glc. Fractions Ia and lb did not react with rabbit 19A antiserum. In contrast, 19A PS Lab-A-2 displayed only one peak, which was eluted by a NaCl gradient (0 to 0.6 M NaCl), and contained only Rha and Glc. The 19A PSs prepared from Lab-A and Centers for Disease Control (CDC) strains and grown in pneumococcal inoculum medium (PIM) and modified Holt medium were chromatographed on a DEAE-Sepharose CL-6B column, and the separated fractions were examined for their sugar composition. The fractions obtained from the 19A PSs Lab-A-PIM and CDC-PIM exhibited four sugar components, as observed for the PS Lab-A-1, while the separated fractions from the 19A PSs Lab-A-Holt and CDC-Holt displayed two sugar components, a pattern similar to that of PS Lab-A-2. Thus, the sugar compositions of 19A PS appeared to vary according to the type of culture medium used to grow the 19A organisms.
The same structure has been proposed for the Streptococcus pneumoniae 19F(19) and 19A(57) capsular polysaccharides (PSs), i.e., 4)-,B-2-acetamido-2-deoxymannose-(1---4)-a-D-Glc-(1--2)-ct-L-Rha-l-phosphate. This trisaccharide is considered the only repeating unit in the type 19F PS. The 19A PS contains, in addition, side chains composed of a 3-D-2-acetamido-deoxyglucose-(1--3)-3-D-Gal-l-phosphate attached to C-2 of Glc and an aX-L-Fuc-l-phosphate attached to C-3 of Rha (9) . A different structure for the pneumococcal type 19A PS has recently been proposed, i.e., -4)-1-DManpNAc-(1--*4)-cx-D-Glcp-(1->3)-a-L-Rhap(1-PO4 )- (7) .
The reason for this difference is not clear. One possibility is that the 19A strain has undergone phenotypic or genetic changes during storage and maintenance. The change in 19A PS structure could also be induced during the growth of bacteria as well as during purification of capsular PS. This report discusses the possible causes for the changes in the 19A PS structure due to culture conditions and examines the immunological implication of these changes.
The following sugar abbreviations are used in this paper: Glc, glucose; Gal, galactose; Fuc, fucose; Rha, rhamnose; Man, mannose.
MATERIALS AND METHODS
Bacterial strains. The S. pneumoniae type 19A strains originated from two sources: (i) a disease isolate, designated CDC strain, was obtained from the Centers for Disease Control, Atlanta, Ga., and (ii) a reference strain was obtained from the Laboratory of Lund and J. Henrichsen, Statens Seruminstitut, Copenhagen, Denmark. The strain stored at the Office of Biologics (OB strain 1) derives from * Corresponding author. this reference strain. The laboratory A seed strain is OB strain 1 and was used commercially to prepare the Lab-A-1, Lab-A-2, and Lab-A-3 PSs. The laboratory maintenance strain, designated Lab-A, is derived from the laboratory A seed strain and was used to prepare Lab-A PSs in this study. To summarize this lineage, Lab-A issues from the Lab-A seed strain, which issues from OB strain 1, which issues from the reference strain. Another strain, designated Lab-B and obtained from G. liter of medium. The medium was adjusted to pH 7.6. (iii) Special brain heart infusion medium was prepared by the method previously described (11) . Type 19A PS was isolated and purified from the culture medium by the method previously described (10) . The special brain heart infusion medium was used to grow the i9A strain stored at the Office of Biologics (OB strain 1).
Chemicals. DEAE-Sepharose CL-6B was purchased from Pharmacia Fine Chemicals, Piscataway, N.J.
Chromatography. Type 19A PS was chromatographed through a DEAE-Sepharose CL-6B column (22 by 2 cm) with a sodium chloride gradient of 0 to 0.6 M in 0.01 M sodium phosphate buffer (pH 7.0) followed by 0.6 to 3 M sodium chloride solution in the same pH 7.0 buffer. The eluate fractions were monitored for PS by the anthrose reaction (3).
Immunodiffusion. Immunodiffusion was performed as previously described (10) .
Chemical analyses. The 19A PS was hydrolyzed with 0.5 N HCl at 100°C for 17 h or with 4 N methanesulfonic acid at 100°C for 20 h. Amino sugars were analyzed on a 121-M amino acid analyzer (Beckman Instruments, Inc., Fullerton, Calif.) (4). Neutral sugars were analyzed by an automatic sugar analyzer (1) or by high-performance liquid chromatography (Waters Associates, Inc., Milford, Mass.) (5, 12) .
RESULTS
Sugar compositions of type 19A PS preparations. Type 19A PSs prepared from different lots and in different laboratories displayed different sugar compositions ( Fig. 1 ; Table 1 ). Acid hydrolysates of 19A PSs from Lab-A lot 1 (Lab-A-1) and lot 3 (Lab-A-3) and that isolated from the 19A strain stored at the Office of Biologics (OB strain 1) showed Fuc and Gal in addition to Rha and Glc, suggesting that these PSs may have side chains in their structure, while the hydrolysates of PS samples from Lab-A lot 2 (Lab-A-2) and Lab-B had only Rha and Glc.
The strain used to prepare the 19A PSs Lab-A-1 and Lab-A-3 was identical to the original OB strain 1. However, the Lab-A-2 and Lab-B preparations of 19A PS showed different sugar compositions from other lots of 19A PSs. The 19F PSs prepared from Lab-A and Lab-B both contained Rha and Glc.
Immunological characteristics. The immunological activities of the various 19A PSs were studied by immunodiffusion (Fig. 2) . The 19A PSs prepared from different lots and laboratories showed identical reactions when reacted with rabbit 19A antiserum ( Fig. 2A and D) . These 19A and 19F PSs showed cross-reactivity when they were reacted with 19A antiserum (Fig. 2A) . Identical cross-reactions of various PS preparations (e.g., Lab-A-1, Lab-B, and Lab-A-3) were observed when these 19A PSs were reacted with rabbit 19F antiserum (Fig. 2B) . Thus, despite their different sugar compositions, these 19A PS preparations appeared to be identified by immunodiffusion with rabbit 19A and 19F antisera.
However, Lab-A-1, Lab-A-3, and Lab-B showed serological activity different from that of the 19A PS prepared from OB strain 1 (Fig. 2C) . In 19A PS prepared from OB strain 1, the pneumococcal cells were grown in a special brain heart infusion medium (11) , which was different from the culture medium (PIM) used to prepare Lab-A-1 and Lab-A-3. The chemical composition and structure of 19A PS were influenced by the type of culture medium used.
DEAE-Sepharose chromatography. The 19A PSs, prepared from cells grown under various conditions, were chromatographed on a DEAE-Sepharose CL-6B column (Fig. 3) . The PS Lab-A-1 was separated into three fractions; fractions Ia and lb (6.67 and 3.26 mg, respectively) were eluted by a gradient of 0 to 0.6 M NaCl in 0.01 M dibasic sodium phosphate solution, while fraction II (26.74 mg) was eluted by a gradient of 0.6 to 3 M NaCl solution. The yield of fraction II was 72.9% of the total (36.67 mg). The recovery of all fractions was 91.7% of the sample (40 mg) delivered to the column. In contrast, i9A PS Lab-A-2 displayed only a single peak, which was eluted by the gradient of 0 to 0.6 M NaCl solution. The PS prepared by laboratory A from the 19A maintenance strain grown in PIM showed two peaks; one fraction was eluted by the 0 to 0.6 M NaCl gradient, while the other fraction was eluted by the 0.6 to 3 M NaCl gradient. Figure 4 shows the sugar composition of acid hydrolysates to 19A PS isolated from the Lab-A 19A strain which was grown in PIM (Lab-A-PIM). When the 19A PS was chromatographed on DEAE-Sepharose, two fractions were separated. Both fractions I and II contained four sugars. Fraction II had Rha, Fuc, Glc, and Gal in equal molar ratio. However, the content of Fuc and Gal in fraction I was less than that of Rha and Glc, indicating that some of the side chains may have been removed. with C-PS (Fig. 5-1) . Fraction II obtained from 19A PS Lab-A-1 reacted with the rabbit 19A antiserum. It exhibited immunological activity identical to that of the 19A PS Lab-A-3 ( Fig. 5-2) .
Effect of culture medium. The 19A PSs prepared from the Lab-A and CDC 19A strains and grown in various culture media were examined for their sugar compositions (Table 2 ). 19A PS Lab-A-1 was prepared in PIM, and Lab-A-2 was prepared in modified PIM in which neopeptone was substituted for soybean protein. In contrast, 19A PS and 19F PS Lab-B were prepared in modified Holt medium. For comparison with these commercial preparations, Lab-A, derived from the laboratory A seed strain, and the CDC strain were cultured in PIM (Lab-A-PIM and CDC-PIM, respectively).
19A PS Lab-A-1 fraction la contained Fuc and Gal, while fraction II contained Fuc, Gal, Rha, and Glc. In contrast, the PS Lab-A-2 fraction contained only Rha and Glc. The The 19A strain in a natural environment, such as CDC strain isolated from patients with pneumonia, was capable of producing four neutral sugar components when it was grown in PIM. Thus, the two neutral sugar components contained in some 19A PSs, e.g., Lab-A-2 and Lab-B, were not caused by the change of 19A strain. Furthermore, when the 19A strains obtained from either Lab-A or Lab-B were grown in the same modified Holt medium, they produced PSs consisting of two neutral sugars. The sugar composition of 19A PS was affected by the type of culture medium used and not by the source of the 19A strain. Type 19A PS Lab-A-1, used in the study of structure determination (9) , was prepared during the 1970s. According to the manufacturer, the 19A PS used by Katzenellenbogen and Jennings (7) was also prepared by laboratory A from the same 19A strain but by a different fermentation process.
It is interesting to note that 19A PS isolated from the same 19A strain has resulted in two proposed chemical structures. In one proposed structure, the 19A PS has been postulated to contain two side chains and a 1-2 linkage between Glc and Rha of the backbone unit; the other type of PS does not have side chains, and there is a 1-3 linkage between Glc and Rha. The Lab-A strain was obtained from the pneumococcal 19A strain stored at the Office of Biologics (OB strain 1). The 19A PS prepared from OB strain 1 also contained Rha, Fuc, Glc, and Gal, the same sugar components contained in PS Lab-A-1. Furthermore, 19A strains obtained from laboratory A and the Centers for Disease Control and grown in PIM also produced PSs that contained these four sugar components. Changing the culture medium to a modified Holt medium appears to change the composition of the type 19A PSs to one containing primarily Rha and Glc. It appears that Lab-A is capable of producing a type 19A PS composed of four neutral sugars as well as one composed of two neutral sugars.
The immunochemical activities of 19A PSs from various preparations indicated that despite their different sugar compositions, these 19A PS preparations appear to be unchanged in serological activity as measured by immunodiffusion. Growth of OB strain 1 in brain heart infusion medium imparts some additional antigenicity to the PS preparation that renders it different from the other type 19A PSs. The specificity of the antiserum needs to be thoroughly characterized before this finding is fully understood. Further study is also necessary to determine the quantity of antibody and the specificity that each of these two types of 19A PSs will elicit in animals.
19A PS Lab-A-1 was separated into three fractions by chromatography through a DEAE-Sepharose CL-6B column and eluted by a gradient of 0 to 0.6 M NaCl, followed by a gradient of 0.6 to 3 M NaCl. The major portion, 72.9% of the material, was recovered in fraction II, which bound tightly to the DEAE-Sepharose column. 19A PS Lab-A-1 fraction lb has been considered to be due to contamination by C-PS, which has the structure: where AAT is 2-acetamido-4-amino-2,4,6-trideoxygalactose (6) The sugar composition of the 19A PS appears to be affected by the nutrients in the culture medium used to grow the organisms. In this study, 19A PSs prepared from Lab-A and CDC 19A strains grown in PIM contained the sugar components Rha, Fuc, Glc, and Gal, while the PSs prepared from the same strains grown in the modified Holt medium contained only the sugar components Rha and Glc. One of the main ingredients in PIM is neopeptone, whereas the modified Holt medium contains Bacto-Peptone (Difco). Both neopeptone and Bacto-Peptone are the enzymatic hydrolysates of proteins. The former contains 3.49% proteose N, 10.72% peptone N (14.33% total N), and 4.72% tyrosine, while the latter contains 0.74% proteose N, 15.38% peptone N (16.16% total N), and 0.98% tyrosine. Both peptones contain similar amounts of amino N, tryptophan, cystine, and phosphorus. Bacto-Peptone has a high peptone and amino acid content and only a negligible quantity of proteoses and more complex nitrogenous constituents. The indole production, maintenance of growth, maximum production of soluble toxins, etc., were reported to be definitely influenced by the nature and character of the peptone and the nitrogenous constituents of the culture medium (2) . The 19A PS prepared from Holt medium supplemented with Fuc and Gal did not contain these side chain components in its PS structure, indicating that the lack of Fuc and Gal components in the 19A PS is not due to the absence of these sugars in the culture medium. Some other factors may be involved. Further studies are needed to investigate the effect of nutritional components on the biological activity of these and other pneumococcal PSs.
